Abstract
The foreword focuses on the three main critical questions within the political debate: (1) Is ADHD a psychiatric disorder? (2) Is there over–diagnosis and overtreatment of ADHD? (3) Are psychostimulants dangerous drugs?
After discussing the problems within the context of general scientific and merely European political context, the authors conclude with a positive outlook comprising (1) step–up of research in ADHD, (2) exercised control over diagnosis and treatment, (3) the need for training and continuous personal development for doctors, and (4) Improvement of information to teachers and parents.
The presented supplement on ”ADHD – beyond core symptoms. Not only a European perspective” underlines this perspective and reflects a broad spectrum of ADHD–related activities currently underway in Europe while having the worldwide development of the field in mind.
Similar content being viewed by others
References
Angold A, Erkanli A, Egger HL, Costello EJ (2000) Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39:975–984
Barkley RA, Fischer M, Smallish L, Fletcher K (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111:97–109
Baumgaertel A, Wolraich ML, Dietrich M (1995) Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 34: 629–638
Biederman J, Wilens T, Mick E, Spencer T, Faraone SV (1999) Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:e20
Burd L, Klug MG, Coumbe MJ, Kerbeshian J (2003) Children and adolescents with attention deficit-hyperactivity disorder: 1.Prevalence and cost of care. J Child Neurol 18:555–561
Council of Europe (2000) Sociocultural Factors and the Treatment of ADHD. Council of Europe, Strasbourg
De Jong PE (1997) Short-term trends in Dutch children’s attention problems. Eur Child Adolesc Psychiatry 6:73–80
DeGrandpre R (1999) Ritalin Nation; Rapid-fire Culture and the Transformation of Human Consciousness. W.W. Norton and Company, New York
Drug Enforcement Administration (1995) Methylphenidate Review. DEA, Washington DC
Gomez R, Harvey J, Quick C, Scharer I, Harris G (1999) DSM-IV AD/HD: Confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. J Child Psychol Psychiatry 40:265–274
Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD (1999) Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 38: 797–804
Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673–1685
Llana ME, Crismon ML (1999) Methylphenidate: increased abuse or appropriate use? J Am Pharmaceutical Assoc 39:526–530
National Institutes of Health (NIH) (2000) National Institutes of Health Consensus development statement: diagnosis and treatment of Attentiondeficit/ Hyperactivity Disorder (ADHD). J Am Acad Child Adolesc Psychiatry 39:182–193
Pollack W (1998) Real Boys: Rescuing our Sons from the Myths of Boyhood. Random House, New York
Rapoport JL, Buchsbaum M, Weingartner H, Zahn TP, Ludlow CL, Mikkelsen EJ (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933–943
Rothenberger A, Banaschewski T (2002) Towards a better drug treatment for patients in Child and Adolescent Psychiatry – the European approach. Eur Child Adolesc Psychiatry 11:243–246
Safer DJ, Krager JM (1992) Effect of a media blitz and a threatened lawsuit on stimulant treatment. J Am Med Assoc 268:1004–1007
Seiden LS, Ricaurte GA (1987) Neurotoxocity of methamphetamine and related drugs. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp 359–366
Sociaal en Cultureel Planbureau (SCP) (1999) Op Weg naar Andere Tijden? SDU, Den Haag
Spensley J, Rockwell DA (1972) Psychosis during methylphenidate abuse. New Engl J Med 286:880–881
Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429–433
Szasz T (1970) The Manufacture of Madness: A Comparative Study of the Inquisition and the Mental Health Movement. Harper & Row, New York
Szasz T (1961) The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. Hoeper Harper, New York
Van Praag HM (1999) Nosologomanie, een aandoening van de psychiatrie. Tijdschrift voor Psychiatrie 12:703–712
Verhulst FC, Van der Ende J, Rietbergen A (1997) Ten-year time trends of psychopathology in Dutch children and adolescents: no evidence for strong trends. Acta Psychiatr Scand 96:7–13
Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456–463
Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30:547–550
Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996) Comparison of diagnostic criteria for attention- deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319–324
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buitelaar, J.K., Rothenberger, A. Foreword – ADHD in the scientific and political context. European Child & Adolescent Psychiatry 13 (Suppl 1), i1–i6 (2004). https://doi.org/10.1007/s00787-004-1001-y
Issue Date:
DOI: https://doi.org/10.1007/s00787-004-1001-y